As of 2026-09-30, the Relative Valuation of Cue Biopharma Inc (CUE) is (418.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.51 USD, the upside of Cue Biopharma Inc based on Relative Valuation is -1740.1%.
The range of the Relative Valuation is (355.40) - (511.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 26.2x | 22.2x |
| Forward P/E multiples | 15.0x - 26.3x | 20.6x |
| Fair Price | (355.40) - (511.62) | (418.38) |
| Upside | -1493.2% - -2105.6% | -1740.1% |
| Date | P/E |
| 2026-09-29 | -1.31 |
| 2026-09-28 | -1.41 |
| 2026-09-25 | -1.61 |
| 2026-09-24 | -1.68 |
| 2026-09-23 | -1.62 |
| 2026-09-22 | -1.58 |
| 2026-09-21 | -1.45 |
| 2026-09-18 | -1.90 |
| 2026-09-17 | -1.94 |
| 2026-09-16 | -1.75 |
| 2026-09-15 | -1.62 |
| 2026-09-14 | -1.56 |
| 2026-09-11 | -1.47 |
| 2026-09-10 | -1.43 |
| 2026-09-09 | -1.56 |
| 2026-09-08 | -1.54 |
| 2026-09-04 | -1.41 |
| 2026-09-03 | -1.42 |
| 2026-09-02 | -1.38 |
| 2026-09-01 | -1.46 |
| 2026-08-31 | -1.31 |
| 2026-08-28 | -1.43 |
| 2026-08-27 | -1.44 |
| 2026-08-26 | -1.48 |
| 2026-08-25 | -1.37 |
| 2026-08-24 | -1.19 |
| 2026-08-21 | -1.23 |
| 2026-08-20 | -1.26 |
| 2026-08-19 | -1.35 |
| 2026-08-18 | -1.32 |
| 2026-08-17 | -1.42 |
| 2026-08-14 | -1.75 |
| 2026-08-13 | -1.59 |
| 2026-08-12 | -1.56 |
| 2026-08-11 | -1.45 |
| 2026-08-10 | -1.34 |
| 2026-08-07 | -1.39 |
| 2026-08-06 | -1.38 |
| 2026-08-05 | -1.36 |
| 2026-08-04 | -1.36 |
| 2026-08-03 | -1.38 |
| 2026-07-31 | -1.37 |
| 2026-07-30 | -1.56 |
| 2026-07-29 | -1.43 |
| 2026-07-28 | -1.55 |
| 2026-07-27 | -1.67 |
| 2026-07-24 | -1.64 |
| 2026-07-23 | -1.69 |
| 2026-07-22 | -1.75 |
| 2026-07-21 | -1.71 |